The Na +/H + exchanger NHE1, but not the Na +, HCO3- cotransporter NBCn1, regulates motility of MCF7 breast cancer cells expressing constitutively active ErbB2

Cancer Letters

Volumn 317, Issue 2, 2012, Pages 172-183

  Lauritzen, Gitte ^a   Stock, Christian Martin ^b   Lemaire, Justine ^a   Lund, Stine F ^a   Jensen, Mie Frid ^a   Damsgaard, Britt ^a   Petersen, Katrine Seide ^a   Wiwel, Maria ^a   Rønnov Jessen, Lone ^a   Schwab, Albrecht ^b   Pedersen, Stine Falsig ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Adhesion; Cytoskeleton; HER2; Motility; PH regulation; Signaling

Indexed keywords

BETA1 INTEGRIN; BICARBONATE SODIUM COTRANSPORTER; COLLAGEN TYPE 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EZRIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MOESIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN S6; RADIXIN; SERINE; SODIUM BICARBONATE COTRANSPORTER 1; SODIUM PROTON EXCHANGE PROTEIN 1; UNCLASSIFIED DRUG;

ACIDIFICATION; ANION EXCHANGE; ARTICLE; BREAST CANCER; CELL ADHESION; CELL MOTILITY; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; ENZYME INHIBITION; INTRACELLULAR SIGNALING; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SODIUM BICARBONATE COTRANSPORTER 1 GENE; SODIUM HYDROGEN EXCHANGER 1 GENE; TUMOR GENE; UPREGULATION;

AMILORIDE; ANTIGENS, CD29; BENZAMIDES; BREAST NEOPLASMS; CATION TRANSPORT PROTEINS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CHROMONES; CULTURE MEDIA, SERUM-FREE; CYTOSKELETAL PROTEINS; ENZYME INHIBITORS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOBLOTTING; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SODIUM-BICARBONATE SYMPORTERS; SODIUM-HYDROGEN ANTIPORTER; SULFONAMIDES;

EID: 84856612269     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.11.023     Document Type: Article

References (67)

1. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Levin W.J., Stuart S.G., Udove J., Ullrich A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989, 244:707-712.
2. Hynes N.E., Lane H.A. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 2005, 5:341-354.
3. Christianson T.A., Doherty J.K., Lin Y.J., Ramsey E.E., Holmes R., Keenan E.J., Clinton G.M. NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer. Cancer Res. 1998, 58:5123-5129.
4. Lauritzen G., Jensen M.B., Boedtkjer E., Dybboe R., Aalkjaer C., Nylandsted J., Pedersen S.F. NBCn1 and NHE1 expression and activity in DeltaNErbB2 receptor-expressing MCF-7 breast cancer cells: contributions to pHi regulation and chemotherapy resistance. Exp. Cell Res. 2010, 316:2538-2553.
5. + exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J. 2000, 14:2185-2197.
6. + exchange. J. Physiol. 2005, 567:225-238.
7. McLean L.A., Roscoe J., Jorgensen N.K., Gorin F.A., Cala P.M. Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes. Am. J. Physiol. Cell Physiol. 2000, 278:C676-C688.
8. + exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J. Biol. Chem. 2004, 279:26991-27007.
9. Krahling H., Mally S., Eble J.A., Noel J., Schwab A., Stock C. The glycocalyx maintains a cell surface pH nanoenvironment crucial for integrin-mediated migration of human melanoma cells. Pflugers Arch. 2009, 458:1069-1083.
10. Yang X., Wang D., Dong W., Song Z., Dou K. Inhibition of Na(+)/H(+) exchanger 1 by 5-(N-ethyl-N-isopropyl) amiloride reduces hypoxia-induced hepatocellular carcinoma invasion and motility. Cancer Lett. 2010, 295:198-204.
11. Ahmed S., Thomas G., Ghoussaini M., Healey C.S., Humphreys M.K., Platte R., Morrison J., Maranian M., Pooley K.A., Luben R., Eccles D., Evans D.G., et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat. Genet. 2009, 41:585-590.
12. Antoniou A.C., Beesley J., McGuffog L., Sinilnikova O.M., Healey S., Neuhausen S.L., Ding Y.C., Rebbeck T.R., Weitzel J.N., Lynch H.T., Isaacs C., Ganz P.A., Tomlinson G., Olopade O.I., Couch F.J., Wang X., et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res. 2010, 70:9742-9754.
13. Parks S.K., Chiche J., Pouyssegur J. pH control mechanisms of tumor survival and growth. J. Cell Physiol. 2011, 226:299-308.
14. Egeblad M., Mortensen O.H., Jaattela M. Truncated ErbB2 receptor enhances ErbB1 signaling and induces reversible, ERK-independent loss of epithelial morphology. Int. J. Cancer 2001, 94:185-191.
15. Lagana A., Vadnais J., Le P.U., Nguyen T.N., Laprade R., Nabi I.R., Noel J. Regulation of the formation of tumor cell pseudopodia by the Na(+)/H(+) exchanger NHE1. J. Cell Sci. 2000, 113(Pt 20):3649-3662.
16. + exchanger NHE1 is required for directional migration stimulated via PDGFR-alpha in the primary cilium. J. Cell Biol. 2009, 185:163-176.
17. Busco G., Cardone R.A., Greco M.R., Bellizzi A., Colella M., Antelmi E., Mancini M.T., Dell'Aquila M.E., Casavola V., Paradiso A., Reshkin S.J. NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space. FASEB J. 2010.
18. Gatenby R.A., Smallbone K., Maini P.K., Rose F., Averill J., Nagle R.B., Worrall L., Gillies R.J. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Brit. J. Cancer 2007, 97:646-653.
19. +-HCO3- cotransport in migration of transformed renal epithelial cells. J. Physiol. 2005, 568:445-458.
20. Lauritzen G., Jensen M.F., Wiwel M., Nylandsted J., Aalkjaer C., Stock C., Schwab A., Pedersen S.F. Roles of pH-regulatory ion transport in motility and survival in MCF-7 breast cancer cells expressing constitutively active ErbB2. J. Physiol. Sci. 2009, 59(Suppl. 1):490.
21. Ch'en F.F., Villafuerte F.C., Swietach P., Cobden P.M., Vaughan-Jones R.D. S0859, an N-cyanosulphonamide inhibitor of sodium-bicarbonate cotransport in the heart. Brit. J. Pharmacol. 2008, 153:972-982.
22. Chen S., Mackintosh C. Differential regulation of NHE1 phosphorylation and glucose uptake by inhibitors of the ERK pathway and p90RSK in 3T3-L1 adipocytes. Cell Signal. 2009, 21:1984-1993.
23. Poulsen K.A., Pedersen S.F., Kolko M., Lambert I.H. Induction of group VIA phospholipase A2 activity during in vitro ischemia in C2C12 myotubes is associated with changes in the level of its splice variants. Am. J. Physiol. Cell Physiol. 2007, 293:C1605-C1615.
24. Rasmussen M., Alexander R.T., Darborg B.V., Mobjerg N., Hoffmann E.K., Kapus A., Pedersen S.F. Osmotic cell shrinkage activates ezrin/radixin/moesin (ERM) proteins: activation mechanisms and physiological implications. Am. J. Physiol. Cell Physiol. 2008, 294:C197-C212.
25. Pedersen S.F., King S.A., Nygaard E.B., Rigor R.R., Cala P.M. NHE1 inhibition by amiloride- and benzoylguanidine-type compounds. Inhibitor binding loci deduced from chimeras of NHE1 homologues with endogenous differences in inhibitor sensitivity. J. Biol. Chem. 2007, 282:19716-19727.
26. Boyarsky G., Ganz M.B., Sterzel R.B., Boron W.F. Acid extrusion in absence and presence of HCO3- Am. J. Physiol. 1988, 255:C844-C856.
27. Stock C., Mueller M., Kraehling H., Mally S., Noel J., Eder C., Schwab A. pH nanoenvironment at the surface of single melanoma cells. Cell Physiol. Biochem. 2007, 20:679-686.
28. Kovbasnjuk O.N., Spring K.R. The apical membrane glycocalyx of MDCK cells. J. Membr. Biol. 2000, 176:19-29.
29. Kirschberger S., Busche R., von E.W. Surface pH at the basolateral membrane of the caecal mucosa of guinea pig. J. Membr. Biol. 1999, 169:111-122.
30. 2+ transport across the plasma membrane for cell migration. Cell Physiol. Biochem. 2005, 16:119-126.
31. Dieterich P., Klages R., Preuss R., Schwab A. Anomalous dynamics of cell migration. Proc. Natl. Acad. Sci. USA 2008, 105:459-463.
32. Schwab A., Wulf A., Schulz C., Kessler W., Nechyporuk-Zloy V., Romer M., Reinhardt J., Weinhold D., Dieterich P., Stock C., Hebert S.C. Subcellular distribution of calcium-sensitive potassium channels (IK1) in migrating cells. J. Cell Physiol. 2006, 206:86-94.
33. Maly K., Strese K., Kampfer S., Ueberall F., Baier G., Ghaffari-Tabrizi N., Grunicke H.H., Leitges M. Critical role of protein kinase C alpha and calcium in growth factor induced activation of the Na(+)/H(+) exchanger NHE1. FEBS Lett. 2002, 521:205-210.
34. Price J.T., Wilson H.M., Haites N.E. Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. Eur. J. Cancer 1996, 32A:1977-1982.
35. + exchanger isoform-1. J. Biol. Chem. 1999, 274:20206-20214.
36. Elliott B.E., Meens J.A., SenGupta S.K., Louvard D., Arpin M. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res. 2005, 7:R365-R373.
37. Li Q., Wu M., Wang H., Xu G., Zhu T., Zhang Y., Liu P., Song A., Gang C., Han Z., Zhou J., Meng L., Lu Y., Wang S., Ma D. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells 4. Cancer Lett. 2008, 261:55-63.
38. Ghatak S., Misra S., Toole B.P. Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J. Biol. Chem. 2005, 280:8875-8883.
39. Denker S.P., Huang D.C., Orlowski J., Furthmayr H., Barber D.L. Direct binding of the Na--H exchanger NHE1 to ERM proteins regulates the cortical cytoskeleton and cell shape independently of H(+) translocation. Mol. Cell 2000, 6:1425-1436.
40. Yao E.S., Zhang H., Chen Y.Y., Lee B., Chew K., Moore D., Park C. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res. 2007, 67:659-664.
41. Tominaga T., Barber D.L. Na-H exchange acts downstream of RhoA to regulate integrin-induced cell adhesion and spreading. Mol. Biol. Cell 1998, 9:2287-2303.
42. 2+ oscillations. J. Biol. Chem. 2009, 284:3855-3864.
43. Destaing O., Block M.R., Planus E., Albiges-Rizo C. Invadosome regulation by adhesion signaling. Curr. Opin. Cell Biol. 2011, 23:597-606.
44. Saez R., Molina M.A., Ramsey E.E., Rojo F., Keenan E.J., Albanell J., Lluch A., Garcia-Conde J., Baselga J., Clinton G.M. p95HER-2 predicts worse outcome in patients with HER-2-positive breast cancer. Clin. Cancer Res. 2006, 12:424-431.
45. Molina M.A., Saez R., Ramsey E.E., Garcia-Barchino M.J., Rojo F., Evans A.J., Albanell J., Keenan E.J., Lluch A., Garcia-Conde J., Baselga J., Clinton G.M. NH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer. Clin. Cancer Res. 2002, 8:347-353.
46. Zhao Y.H., Zhou M., Liu H., Ding Y., Khong H.T., Yu D., Fodstad O., Tan M. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. Oncogene 2009, 28:3689-3701.
47. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
48. + efflux by the Na-H exchanger NHE1 for polarity of migrating cells. J. Cell Biol. 2007, 179:403-410.
49. Martin C., Pedersen S.F., Schwab A., Stock C. Intracellular pH gradients in migrating cells. Am. J. Physiol. Cell Physiol. 2011, 300:C490-C495.
50. Frantz C., Barreiro G., Dominguez L., Chen X., Eddy R., Condeelis J., Kelly M.J., Jacobson M.P., Barber D.L. Cofilin is a pH sensor for actin free barbed end formation: role of phosphoinositide binding. J. Cell Biol. 2008.
51. Srivastava J., Barreiro G., Groscurth S., Gingras A.R., Goult B.T., Critchley D.R., Kelly M.J., Jacobson M.P., Barber D.L. Structural model and functional significance of pH-dependent talin-actin binding for focal adhesion remodeling. Proc. Natl. Acad. Sci. USA 2008, 105:14436-14441.
52. Stock C., Cardone R.A., Busco G., Krahling H., Schwab A., Reshkin S.J. Protons extruded by NHE1: digestive or glue?. Eur. J. Cell Biol. 2008.
53. Ro H.A., Carson J.H. pH microdomains in oligodendrocytes. J. Biol. Chem. 2004, 279:37115-37123.
54. Reshkin S.J., Bellizzi A., Albarani V., Guerra L., Tommasino M., Paradiso A., Casavola V. Phosphoinositide 3-kinase is involved in the tumor-specific activation of human breast cancer cell Na(+)/H(+) exchange, motility, and invasion induced by serum deprivation. J. Biol. Chem. 2000, 275:5361-5369.
55. Rae J.M., Creighton C.J., Meck J.M., Haddad B.R., Johnson M.D. MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res. Treat. 2007, 104:13-19.
56. Narita T., Kimura N., Sato M., Matsuura N., Kannagi R. Altered expression of integrins in adriamycin-resistant human breast cancer cells. Anticancer Res. 1998, 18:257-262.
57. Eble J.A., Tuckwell D.S. The alpha2beta1 integrin inhibitor rhodocetin binds to the A-domain of the integrin alpha2 subunit proximal to the collagen-binding site. Biochem. J. 2003, 376:77-85.
58. Lehenkari P.P., Horton M.A. Single integrin molecule adhesion forces in intact cells measured by atomic force microscopy. Biochem. Biophys. Res. Commun. 1999, 259:645-650.
59. Paradise R.K., Lauffenburger D.A., Van Vliet K.J. Acidic extracellular pH promotes activation of integrin alpha(v)beta(3). PLoS ONE 2011, 6:e15746.
60. + exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival. J. Biol. Chem. 2004, 279:26280-26286.
61. Yuan K., Frolova N., Xie Y., Wang D., Cook L., Kwon Y.J., Steg A.D., Serra R., Frost A.R. Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues. J. Histochem. Cytochem. 2010, 58:857-870.
62. Kocher H.M., Sandle J., Mirza T.A., Li N.F., Hart I.R. Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells. Gut 2009, 58:271-284.
63. Doehn U., Hauge C., Frank S.R., Jensen C.J., Duda K., Nielsen J.V., Cohen M.S., Johansen J.V., Winther B.R., Lund L.R., Winther O., Taunton J., Hansen S.H., Frodin M. RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. Mol. Cell 2009, 35:511-522.
64. Larrea M.D., Hong F., Wander S.A., da Silva T.G., Helfman D., Lannigan D., Smith J.A., Slingerland J.M. RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc. Natl. Acad. Sci. USA 2009, 106:9268-9273.
65. Woo M.S., Ohta Y., Rabinovitz I., Stossel T.P., Blenis J. Ribosomal S6 kinase (RSK) regulates phosphorylation of filamin A on an important regulatory site. Mol. Cell Biol. 2004, 24:3025-3035.
66. Kelley L.C., Hayes K.E., Ammer A.G., Martin K.H., Weed S.A. Revisiting the ERK/Src cortactin switch. Commun. Integr. Biol. 2011, 4:205-207.
67. + exchanger NHE1. Circ. Res. 2008, 103:881-890.